Back

Vaccination delivery pathways in remotely monitored heart failure: community pharmacy predominance with sex- and age-related differences.

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: global insights Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Olivier Hanon

Hospital Broca of Paris, Paris (France)

5 More presentations in this session

Presentation thumbnail
Age-adjusted sex differences in pneumococcal vaccination uptake in remotely monitored heart failure: a cross-sectional survey
Doctor R. Esser (Versailles, FR)
Abstract
Presentation thumbnail
Socioeconomic and cardiometabolic determinants of long term mortality in heart failure in comparison with general population
Doctor T. Rywik (Warsaw, PL)
Abstract
Presentation thumbnail
Intravenous diuretics for heart failure at home- are we delaying the inevitable?
Doctor M. Nehra (Blackpool, GB) Doctor K. Wong (Blackpool, GB)
Abstract
Presentation thumbnail
Baseline characteristics of participants in MEDLY Uganda: a stepped-wedge cluster randomized type 2 hybrid implementation trial of heart failure care in Uganda
Doctor I. Ssinabulya (Kampala, UG)
Abstract
Presentation thumbnail
Epidemiology of heart failure in Niger: a retrospective study (January 2019 - December 2025)
Professor I. Ali Toure (Niamey, NE)
Abstract

Access the full session

Session thumbnail
Heart failure: global insights

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Community pharmacy as the main vaccinator in remotely monitored heart failure patients: sex- and age-related differences in vaccination pathways.
10 May 2026
thumbnail
Congress Presentation
Heart failure community service redesign during first wave of coronavirus pandemic in a highly affected area
29 June 2021
thumbnail
Congress Presentation
Impact of influenza and pneumococcal vaccines upon in-hospital mortality in patients with heart failure: a retrospective cohort study in the United States
1 September 2020
thumbnail
Congress Presentation
mRNA vaccines for COVID-19 are safe and effective in patients with cardiac amyloidosis
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources